2. Search Result
Search Result
Results for "

paramagnetic contrast

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-107353
    Gadopentetic acid
    2 Publications Verification

    Gd-DTPA; gadolinium complex

    		 Biochemical Assay Reagents Others
    Gadopentetic acid (Gd-DTPA) is a paramagnetic contrast agent. Gadopentetic acid commonly implemented by a bolus intravenous injection in Dynamic contrast-enhanced MRI (DCE-MRI) studies. Gadopentetic acid also can be used for the research of nephrogenic systemic fibrosis (NSF) .
    Gadopentetic acid
  • HY-148465
    Gadoteric acid

    		Biochemical Assay Reagents Cardiovascular Disease Cancer
    Gadoteric acid is a macrocyclic, paramagnetic, gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) of the brain, spine, and related tissues. In particular, Gadoteric acid is able to detect and visualize areas of blood-brain barrier disruption and abnormal vascular distribution .
    Gadoteric acid
  • HY-16217
    Gadobutrol
    1 Publications Verification

    ZK 135079

    		 Biochemical Assay Reagents Cancer
    Gadobutrol (Gd-DO3A-butrol; ZK 135079) is a nonionic paramagnetic macrocyclic gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) .
    Gadobutrol
  • HY-136476A
    Mn(II) protoporphyrin IX

    		Biochemical Assay Reagents Others
    Mn(II) protoporphyrin IX is a potential intravenous paramagnetic magnetic resonance contrast agent. Mn(II) protoporphyrin IX maintains strong paramagnetic properties .
    Mn(II) protoporphyrin IX
  • HY-16217A
    Gadobutrol hydrate

    ZK 135079 hydrate

    		 Biochemical Assay Reagents Others
    Gadobutrol (ZK 135079) hydrate is a nonionic paramagnetic macrocyclic gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) .
    Gadobutrol hydrate
  • HY-108760
    Gadoterate meglumine

    Gd-DOTA; Magnescope; P-449

    		 Biochemical Assay Reagents Cardiovascular Disease Others Neurological Disease
    Gadoterate meglumine (Gd-DOTA; P-449) is a non-specific paramagnetic gadolinium complex used as a contrast enhancer in magnetic resonance imaging (MRI). Gadoterate meglumine paramagnetics in MRI can change the uniformity of the local magnetic field, resulting in a shorter relaxation time for neighboring protons. Gadoterate meglumine's gadoterate ions combine with the ligand DOTA (1,4,7, 10-Tetraazacyclododecane-N,N',N ",N "-tetraacetic acid) to form a stable complex. This stability helps prevent gadolinium ions from dissociating from the complex, thereby reducing potential toxicity. Gadoterate meglumine, as a contrast agent in MRI, is able to shorten the longitudinal relaxation time (T1) of tissue, resulting in a brighter signal in MRI images. Gadoterate meglumine can be used for the study of the central nervous system (such as the brain and spinal cord), abdominal, pelvic organs, breast, bone and joint imaging, angiography, and cardiac electrophysiology .
    Gadoterate meglumine

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: